MedPath

四川金药师制药有限公司

Ownership
-
Established
1997-09-03
Employees
-
Market Cap
-
Website
www.scmeidi.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

57

NMPA:57

Drug Approvals

痛经胶囊

Approval Number
国药准字Z20133049
Approval Date
Apr 7, 2024
NMPA

盆炎净胶囊

Approval Number
国药准字Z20133046
Approval Date
Apr 7, 2024
NMPA

Rutinum

Product Name
芦丁
Approval Number
国药准字H51021513
Approval Date
Oct 13, 2020
NMPA

Berberine Hydrochloride

Product Name
盐酸小檗碱
Approval Number
国药准字H51021520
Approval Date
Oct 13, 2020
NMPA

Rifampicin Capsules

Product Name
利福平胶囊
Approval Number
国药准字H51021512
Approval Date
Oct 13, 2020
NMPA

冠脉宁片

Approval Number
国药准字Z20063517
Approval Date
Sep 28, 2020
NMPA

Tabellae Rhei et Natrii Bicarbonatis

Product Name
大黄碳酸氢钠片
Approval Number
国药准字H51021671
Approval Date
Jun 4, 2020
NMPA

Rotundine Tablets

Product Name
罗通定片
Approval Number
国药准字H51021523
Approval Date
Jun 4, 2020
NMPA

Tabellae Gentianae et Natrii Bicarbonatis

Product Name
龙胆碳酸氢钠片
Approval Number
国药准字H51021677
Approval Date
Jun 4, 2020
NMPA

Sodium Bicarbonate Tablets

Product Name
碳酸氢钠片
Approval Number
国药准字H51021679
Approval Date
Jun 4, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.